Meeting
2023 ASCO Annual Meeting
CONSENT: Randomized controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials.
Authors
Abhijit Pal
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom
Abhijit Pal , Robert Daly , Sarah Stapleton , Christina Yap , Martin Hong , Rafael Grochot , Shybi MohamedKhan , Julia Elizabeth Lai-Kwon , Dimitrios Magkos , Bindumalini Rao Baikady , Anna Rachel Minchom , Udai Banerji , Johann S. De Bono , Deme John Karikios , Frances M. Boyle , Juanita Suzanne Lopez
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Quality Improvement
Clinical Trial Registration Number
NCT04407676
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6560)
DOI
10.1200/JCO.2023.41.16_suppl.6560
Abstract #
6560
Poster Bd #
52
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Imbalance in treatment discontinuation without progression between experimental and control arms among randomized trials in advanced breast cancer.
First Author: Faris Tamimi
Poster
2017 ASCO Annual Meeting
Agreement about end-of-life (EOL) care among advanced cancer patients and their caregivers: Associations with care received.
First Author: Charles Stewart Kamen
Poster
2024 ASCO Annual Meeting
Evaluation of the study of control arms in randomized clinical trials of cancer.
First Author: Sandeep Kumar Jain
Poster
2024 ASCO Genitourinary Cancers Symposium
Toxicity-benefit analysis of advanced prostate cancer trials using weighted toxicity scoring.
First Author: Jaspreet Kaur Gill